Enable Accessibility Enable Accessibility

Corporate Philosophy

As a global biopharmaceutical leader, it’s important to have a strong corporate philosophy. Our culture is rooted in an ideology we call “Takeda-ism”, and we have cultivated our corporate philosophy in the following core components: Mission, Vision , Values, and Strategic Roadmap.


Our Mission is to strive towards Better Health and a Brighter Future for people worldwide through leading innovation in medicine.


We serve the needs of our patients wherever they are. We earn the trust of society and customers through what we call Takeda-ism. We are recognized as the best in class because of our agility and innovation - qualities that help us build a steady pipeline and deliver growth, year on year.



Our philosophy of Takeda-ism, which includes integrity, fairness, honesty, and perseverance, is deeply ingrained in the way we work. Equally important to this are our priority of being patient-centric, maintaining trust, and taking care of our reputation and business. We use Takeda-ism and priorities to make all our decisions, ensuring our commitment to quality and making sure we are doing the right thing at all times.

Takeda has an unwavering commitment to patients and has built a patient-centric and customer-centric organization. Our local organizations are empowered to respond in the best way to meet patient and customer needs.

Our employees are the cornerstone of our success. We create a diverse, inclusive, safe, open and collaborative working environment where employees can contribute, perform and grow as individuals.


Takeda has a world-class R&D engine, making an impact on patients’ lives by translating science into life-changing medicines.

As an R&D-driven company, we focus our research efforts to be at the cutting edge of innovation. We have research centers focusing on four core therapy areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI).

Our productive R&D engine uses a combined approach of internal and external innovation to deliver a sustainable pipeline. We also have the ambition to be among the best partners in the industry.

Business Performance

Takeda is focused on long-term profitable growth through six business drivers. These include our four core therapy areas of Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI), and additionally Plasma-Derived Therapies (PDT) and Vaccines.

Strong financial discipline helps us to deliver profitable growth and provide the broadest possible access to our medicines. This enables us to increase our focus and do more for patients with unmet medical needs.

Related Content